Bridge to Breakthrough Science
Gilead Sciences (cymabay.com) earns a Brand Analyzer score of 82 out of 100, placing it in the Strong Brand tier among Healthcare brands. Among 4101 Healthcare brands analyzed, Gilead Sciences ranks in the 82nd percentile (category average 73, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 80/100, Digital Presence 100/100, Visual Identity 96/100, Messaging Clarity 95/100, Trust Foundation 90/100, AI Discoverability 80/100, Brand Authority 45/100.
Gilead Sciences is an American biopharmaceutical company founded in 1987 and headquartered in Foster City, California. It develops and markets therapies focused on HIV, liver disease, cancer, and inflammatory conditions. The company emphasizes scientific innovation to create transformative treatments for patients, healthcare providers, and communities worldwide. Daniel O'Day serves as CEO. Gilead is positioned as a leader in high-need therapeutic areas within the healthcare and pharmaceutical industry.
| Brand Name | Gilead Sciences |
|---|---|
| Domain | cymabay.com |
| Industry | Healthcare |
| Founded | 1987 |
| Headquarters | Foster City |
| Parent Company / Owner | BlackRock |
| CEO | Daniel O'Day |
| Main Competitors | Pfizer (89/100), Merck & Co. (81/100), Bristol Myers Squibb (84/100), AbbVie (84/100), Johnson & Johnson (87/100), GlaxoSmithKline (ViiV Healthcare) (83/100), Roche (81/100), Amgen (82/100) |
Moz Domain Authority 38/100 vs category average 37 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Gilead Sciences has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation." (Meta description: 24 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, og:image, og:type, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Gilead Sciences scores 53/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Gilead Sciences has a limited AI-visibility profile at 53/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (65/100) and its weakest is trust (33/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 38/100 and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Gilead Sciences's main competitors include Pfizer (89/100), Merck & Co. (81/100), Bristol Myers Squibb (84/100), AbbVie (84/100), Johnson & Johnson (87/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Gilead Sciences and Roche are competitors in Healthcare. Brand Analyzer scores Gilead Sciences at 82/100 and Roche at 93/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Gilead Sciences include Pfizer (89/100), Merck & Co. (81/100), Bristol Myers Squibb (84/100), AbbVie (84/100), Johnson & Johnson (87/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Gilead Sciences is an American biopharmaceutical company founded in 1987 and headquartered in Foster City, California. It researches, develops, and commercializes medicines aimed at treating serious diseases, with a particular focus on HIV, liver disease, cancer, and inflammatory conditions.
Sources: Gilead Sciences official site
Gilead Sciences has moderate AI-search visibility, scoring 53/100 on Brand Analyzer's AI visibility composite (visibility 65, trust 33, recommendation 57). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Gilead Sciences official site
Gilead Sciences was founded in 1987. Gilead Sciences operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Gilead Sciences is headquartered in Foster City. Gilead Sciences operates in the Healthcare category.
Sources: Wikidata
Gilead Sciences develops transformative therapies through scientific research, focusing on treatments for HIV, liver disease, cancer, and inflammation. It works to bring these therapies to patients, healthcare providers, and communities worldwide, aiming to improve health outcomes and advance health equity.
Sources: Gilead Sciences official site
Gilead Sciences scores 57/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Gilead Sciences official site
Gilead Sciences offers biopharmaceutical products and therapies targeting HIV, liver disease, cancer, and inflammatory conditions. The company develops treatments intended to address serious and complex diseases through scientific research and innovation.
Sources: Gilead Sciences official site
Gilead Sciences can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Gilead Sciences official site
Gilead Sciences is known for its leadership in developing treatments for HIV and liver disease, as well as its growing presence in oncology and inflammatory disease research. The company is recognized within the biopharmaceutical industry for its focus on scientific innovation in high-need therapeutic areas.
Sources: Gilead Sciences official site
Gilead Sciences is owned by or part of BlackRock. Gilead Sciences operates in the Healthcare category.
Sources: Wikidata
Gilead Sciences' products and research serve patients affected by HIV, liver disease, cancer, and inflammatory conditions, as well as healthcare providers who administer its therapies. The broader medical and scientific community also engages with Gilead's research and clinical developments.
Sources: Gilead Sciences official site
Ranked closest to Gilead Sciences: Curve Dental (82/100), Coverall (82/100), David Lloyd Clubs (82/100), Dazos (82/100).
A step up - brands to learn from: theSkimm (91/100), Oura (91/100).
Category leader: Elsevier (96/100).